17-Mar-2010 - US drug giant Pfizer will assess Tekimra Pharmaceuticals’s stable nucleic acid-lipid particle (SNALP) platform for the delivery of siRNA drugs.
16-Mar-2010 - US Food and Drug Administration (FDA) request for more Afrezza data is not safety related and will not require new clinical trials, says developer MannKind.
11-Mar-2010 - US devices specialist MedPro Safety Products and Helvoet Pharma have teamed up to develop the former’s range of prefilled safety syringes (PFSS).
11-Mar-2010 - Stason Pharmaceuticals’ subsidiary Standard Chem and Pharm will act as primary distributor for the Unitract 1ml safety syringe in China, Japan and Taiwan under a five-year new deal with US delivery device maker Unilife.
08-Mar-2010 - Inovio Biomedical has developed a hand-held, cordless electroporation device, Cellectra-SP, which it believes is well suited to administering DNA vaccines in mass immunization programmes.
03-Mar-2010 - Sanofi Aventis has paid Unilife €10m for exclusive rights to use its Unifill ready-to-fill (RTF) syringe for the delivery of anti-thrombotic agents and vaccines.
02-Mar-2010 - Merrion Pharmaceuticals’ GIPET technology has been granted US patent protection for use with bisphosphonates.
02-Mar-2010 - PARI Respiratory Equipment has launched its Vios aerosol delivery system to provide a tool for quickly administering treatments to the lungs, with a small particle size and high respirable drug dose.
23-Feb-2010 - Helvoet Pharma is to build a €14m ($19m) rubber parenteral packaging component facility in India to meet rising demand for products made to international quality standards.
22-Feb-2010 - West Pharmaceutical Services reported strong fourth quarter results, underpinned by demand for H1N1 components, but still posted a dip in operating income for its 2009 financial year.
17-Feb-2010 - Hospira’s acquisition of Orchid Chemicals and Pharmaceuticals generic injectables business is on track to complete next month now the Hart-Scott-Rodino period required by the US Federal Trade Commission has elapsed.
16-Feb-2010 - Rusnano, the group set up to promote Russia’s nanotechnology infrastructure, says nanodrug development partnership will improve patient access and cut cancer death rates across the country.
10-Feb-2010 - US biotechnology firm NexBio has received a patent for “pioneering” host cell-targeting influenza drugs that can cut the risk of viral mutation and the emergence of drug resistant strains.
09-Feb-2010 - MDRNA’s liposomal drug delivery formulation, DiLA2, lost no potency when stored for 12 months in conditions ranging from -80ºC to 4ºC, helping to validate it for administration of UsiRNA.
04-Feb-2010 - Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.
02-Feb-2010 - In-PharmaTechnologist presents a round up of recent developments in the field of drug delivery, with new deals for Starpharma and Penwest, and a regulatory filing for Hovione.
28-Jan-2010 - Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further its development.
27-Jan-2010 - Copley Scientific claims new dissolution testing apparatus is first commercially available device specifically designed for inhaled drug formulations.
26-Jan-2010 - LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.
26-Jan-2010 - Nipro Medical has recalled all batches of its GlucoPro insulin syringes in the US after discovering that the needles could detach during use.
25-Jan-2010 - Indian CRO Ankur Drugs and Pharma is a step closer to stating production of Romaco’s Siebler StripTabs now the German firm developed a fully integrated manufacturing line.
25-Jan-2010 - SurModics has opened a 90,000 sq ft cGMP manufacturing and development facility in Birmingham, Alabama, US to support its partnerships and shorten time to market.
20-Jan-2010 - Ocelus’ has received £500,000 from Finance Wales and the Welsh Assembly Government to fund the development of its Microplant Delivery System.
20-Jan-2010 - Access Pharmaceuticals’ insulin diabetes treatment has shown promise in preclinical trials, achieving over 80 per cent oral bioavailability, leading the company to target proof-of-concept studies in humans.
11-Jan-2010 - US FDA has missed its review deadline for MannKind’s inhaled insulin candidate Afrezza after failing to complete inspection of third-party contract supplier.